Oral Versus Intravenous Iron for Anemia Diagnosed After 34 Weeks of Gestation

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-50
SponsorUniversity of Roma La Sapienza

About this trial

This study aims to address this evidence gap by comparing a step-up oral-first strategy with an early IV iron strategy in pregnant women diagnosed with anemia after 34 weeks of gestation.

Eligibility criteria

Qualifiers

• Women aged 18 years or older.

Singleton pregnancy.

Gestational age ≥34+0 weeks at the time of anemia diagnosis.

Hemoglobin <11 g/dL measured as part of routine antenatal care.

Disqualifiers

• Known anemia not primarily due to iron deficiency.

Known hemoglobinopathies.

Severe anemia requiring immediate blood transfusion.

Previous severe hypersensitivity reaction to IV iron formulations.

Trial design

Treatments tested in this trial

  • Oral iron supplementation
  • IV iron administration

Treatment groups

128 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators